FDA Warning Letter — Tianjin Zhongan Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Tianjin Zhongan Pharmaceutical Co., Ltd. on June 10, 2014 (Tianjin, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Tianjin Zhongan Pharmaceutical Co., Ltd.
- Date
- June 10, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Center
- CDER
- Location
- Tianjin (China)